Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001272
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Brief Title:
A Phase I Study of Taxol Cisplatin Cyclophosphamide and Granulocyte Colony-Stimulating Factor G-CSF in Previously Nontreated Ovarian Cancer Patients
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
A Phase I Study of Taxol Cisplatin Cyclophosphamide and Granulocyte Colony-Stimulating Factor G-CSF in Previously Nontreated Ovarian Cancer Patients
Status:
COMPLETED
Status Verified Date:
1999-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase I study which addresses the feasibility and toxicity of adding taxol to the two drug combination which now comprises the standard of care in newly diagnosed advanced stage ovarian cancer cisplatin and cyclophosphamide These drugs will be given in a dose intensive fashion with the colony-stimulating factor G-CSF Newly diagnosed patients with ovarian cancer will be treated with this regimen to determine the optimal dose of this combination The pharmacokinetics of taxol and cisplatin DNA-adducts will be studied as well
Detailed Description:
This is a Phase I study which addresses the feasibility and toxicity of adding taxol to the two drug combination which now comprises the standard of care in newly diagnosed advanced stage ovarian cancer cisplatin and cyclophosphamide These drugs will be given in a dose intensive fashion with the colony-stimulating factor G-CSF Newly diagnosed patients with ovarian cancer will be treated with this regimen to determine the optimal dose of this combination The pharmacokinetics of taxol and cisplatin DNA-adducts will be studied as well
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 91-C-0232 | None | None | None |